Adial Pharmaceuticals, Inc. Derivative Liability, Current
Adial Pharmaceuticals, Inc. (ADIL) had Derivative Liability, Current of $752 as of 2018-06-30, per its 10-Q filed 2018-09-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2019-02-19
- 2018-06-30: Derivative Liability, Current $752.00.
- 2017-12-31: Derivative Liability, Current $752.00.
| Period end | Derivative Liability, Current |
|---|---|
| 2018-06-30 | $752.00 10-Q · filed 2018-09-10 |
| 2017-12-31 | $752.00 10-K · filed 2019-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |